1. HBW Insight
  2. >>Ingredients & Safety
  3. >>Cannabis/CBD

US Hemp Product Industry ‘Dying On Vine’ Without Lawful Use Legislation Or Enforcement Guidance

 
• By Malcolm Spicer

FDA’s tolerance of sales of hemp-containing supplements isn’t the assurance  industry needs for investing in development of ingredients and products which have been shown to provide various health benefits.

• Source: Alamy

It’s not without effort by US industry stakeholders that no progress has been made on establishing a regulatory pathway allowing the use of hemp in dietary supplements. Their efforts likely won’t be rewarded soon, said attorneys at a recent Food and Drug Law Institute conference.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Cannabis/CBD

More from Ingredients & Safety

AESGP Slams ‘Deeply Concerning And Discriminatory’ EU Wastewater Directive

 
• By David Ridley

“Protecting the environment is a shared responsibility. It is unfair to expect only two sectors to fund wastewater treatment modernization and operation,” argues AESGP director general Jurate Švarcaite.

Red Yeast Rice Supplements Facing EU Ban Following Safety Review

 
• By Tom Gallen

Supplements already under close scrutiny in the EU have been linked to severe adverse effects on the musculoskeletal system and liver, even at low doses.

OTC Sildenafil Not Coming To Australia Any Time Soon

 
• By Tom Gallen

Australian government finds an insufficient body of new evidence to support Rx-to-OTC switch of erectile dysfunction drug sildenafil since it was last considered in 2020.